Jong Mi Lim

Title: Jong Mi Lim - Innovator in Transdermal Drug Delivery Systems

Introduction

Jong Mi Lim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on transdermal applications. His research focuses on enhancing the effectiveness of drug delivery through the skin.

Latest Patents

Jong Mi Lim holds a patent for a transdermal drug delivery system featuring a multi-lamellar emulsion structure. This system is designed for transdermal absorption and includes lipids such as long-chain amides, sterols, fatty acids, and fatty alcohols. Additionally, it incorporates an emulsifier, oil, and at least one drug for transdermal administration. The unique lamellar structure of this delivery system mimics the layered structure found in the stratum corneum intercellular lipids of the human body. This design enhances the skin barrier effect and allows for effective drug partitioning through skin lipids, resulting in an excellent drug delivery effect. Jong Mi Lim has 1 patent to his name.

Career Highlights

Jong Mi Lim is currently associated with Neopharm Co., Ltd., where he continues to develop innovative solutions in the pharmaceutical field. His work has garnered attention for its potential to improve patient outcomes through more effective drug delivery methods.

Collaborations

Jong Mi Lim collaborates with Ji Yeon Park, contributing to advancements in their shared field of expertise. Their partnership exemplifies the importance of teamwork in driving innovation.

Conclusion

Jong Mi Lim's contributions to transdermal drug delivery systems highlight his role as a key innovator in the pharmaceutical industry. His patented technology promises to enhance the effectiveness of drug administration, ultimately benefiting patients worldwide.